Literature DB >> 34131804

Prediction of H3K27M-mutant brainstem glioma by amide proton transfer-weighted imaging and its derived radiomics.

Zhizheng Zhuo1, Liying Qu1, Peng Zhang2, Liwei Zhang3, Yaou Liu4, Yunyun Duan1, Dan Cheng1, Xiaolu Xu1, Ting Sun1, Jinli Ding1, Cong Xie1, Xing Liu5, Sven Haller6, Frederik Barkhof7,8.   

Abstract

PURPOSE: H3K27M-mutant associated brainstem glioma (BSG) carries a very poor prognosis. We aimed to predict H3K27M mutation status by amide proton transfer-weighted (APTw) imaging and radiomic features.
METHODS: Eighty-one BSG patients with APTw imaging at 3T MR and known H3K27M status were retrospectively studied. APTw values (mean, median, and max) and radiomic features within manually delineated 3D tumor masks were extracted. Comparison of APTw measures between H3K27M-mutant and wildtype groups was conducted by two-sample Student's T/Mann-Whitney U test and receiver operating characteristic curve (ROC) analysis. H3K27M-mutant prediction using APTw-derived radiomics was conducted using a machine learning algorithm (support vector machine) in randomly selected train (n = 64) and test (n = 17) sets. Sensitivity analysis with additional random splits of train and test sets, 2D tumor masks, and other classifiers were conducted. Finally, a prospective cohort including 29 BSG patients was acquired for validation of the radiomics algorithm.
RESULTS: BSG patients with H3K27M-mutant were younger and had higher max APTw values than those with wildtype. APTw-derived radiomic measures reflecting tumor heterogeneity could predict H3K27M mutation status with an accuracy of 0.88, sensitivity of 0.92, and specificity of 0.80 in the test set. Sensitivity analysis confirmed the predictive ability (accuracy range: 0.71-0.94). In the independent prospective validation cohort, the algorithm reached an accuracy of 0.86, sensitivity of 0.88, and specificity of 0.85 for predicting H3K27M-mutation status.
CONCLUSION: BSG patients with H3K27M-mutant had higher max APTw values than those with wildtype. APTw-derived radiomics could accurately predict a H3K27M-mutant status in BSG patients.

Entities:  

Keywords:  Amide proton transfer–weighted imaging; Brainstem glioma; H3K27M-mutant; Machine learning; Radiomics

Year:  2021        PMID: 34131804     DOI: 10.1007/s00259-021-05455-4

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  27 in total

1.  Advanced MR imaging and 18F-DOPA PET characteristics of H3K27M-mutant and wild-type pediatric diffuse midline gliomas.

Authors:  Arnoldo Piccardo; Domenico Tortora; Samantha Mascelli; Mariasavina Severino; Gianluca Piatelli; Alessandro Consales; Marco Pescetto; Veronica Biassoni; Elisabetta Schiavello; Michela Massollo; Antonio Verrico; Claudia Milanaccio; Maria Luisa Garrè; Andrea Rossi; Giovanni Morana
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-04-27       Impact factor: 9.236

2.  Molecular profiling of tumors of the brainstem by sequencing of CSF-derived circulating tumor DNA.

Authors:  Changcun Pan; Bill H Diplas; Xin Chen; Yuliang Wu; Xiong Xiao; Liping Jiang; Yibo Geng; Cheng Xu; Yu Sun; Peng Zhang; Wenhao Wu; Yu Wang; Zhen Wu; Junting Zhang; Yuchen Jiao; Hai Yan; Liwei Zhang
Journal:  Acta Neuropathol       Date:  2018-11-20       Impact factor: 17.088

3.  Magnetic resonance spectroscopic detection of lactate is predictive of a poor prognosis in patients with diffuse intrinsic pontine glioma.

Authors:  Fumiyuki Yamasaki; Kaoru Kurisu; Yoshinori Kajiwara; Yosuke Watanabe; Takeshi Takayasu; Yuji Akiyama; Taiichi Saito; Ryosuke Hanaya; Kazuhiko Sugiyama
Journal:  Neuro Oncol       Date:  2011-06-08       Impact factor: 12.300

Review 4.  Imaging Correlates of Adult Glioma Genotypes.

Authors:  Marion Smits; Martin J van den Bent
Journal:  Radiology       Date:  2017-08       Impact factor: 11.105

5.  Three-dimensional amide proton transfer MR imaging of gliomas: Initial experience and comparison with gadolinium enhancement.

Authors:  Jinyuan Zhou; He Zhu; Michael Lim; Lindsay Blair; Alfredo Quinones-Hinojosa; Steven A Messina; Charles G Eberhart; Martin G Pomper; John Laterra; Peter B Barker; Peter C M van Zijl; Jaishri O Blakeley
Journal:  J Magn Reson Imaging       Date:  2013-02-25       Impact factor: 4.813

6.  Histone Variant and Cell Context Determine H3K27M Reprogramming of the Enhancer Landscape and Oncogenic State.

Authors:  Surya Nagaraja; Michael A Quezada; Shawn M Gillespie; Marlene Arzt; James J Lennon; Pamelyn J Woo; Volker Hovestadt; Madhuri Kambhampati; Mariella G Filbin; Mario L Suva; Javad Nazarian; Michelle Monje
Journal:  Mol Cell       Date:  2019-10-03       Impact factor: 17.970

7.  Histone H3.3 K27M Accelerates Spontaneous Brainstem Glioma and Drives Restricted Changes in Bivalent Gene Expression.

Authors:  Jon D Larson; Lawryn H Kasper; Barbara S Paugh; Hongjian Jin; Gang Wu; Chang-Hyuk Kwon; Yiping Fan; Timothy I Shaw; André B Silveira; Chunxu Qu; Raymond Xu; Xiaoyan Zhu; Junyuan Zhang; Helen R Russell; Jennifer L Peters; David Finkelstein; Beisi Xu; Tong Lin; Christopher L Tinkle; Zoltan Patay; Arzu Onar-Thomas; Stanley B Pounds; Peter J McKinnon; David W Ellison; Jinghui Zhang; Suzanne J Baker
Journal:  Cancer Cell       Date:  2018-12-27       Impact factor: 31.743

Review 8.  Brainstem glioma: a review.

Authors:  Sean A Grimm; Marc C Chamberlain
Journal:  Curr Neurol Neurosci Rep       Date:  2013-05       Impact factor: 5.081

9.  Spatial genomic heterogeneity in diffuse intrinsic pontine and midline high-grade glioma: implications for diagnostic biopsy and targeted therapeutics.

Authors:  Lindsey M Hoffman; Mariko DeWire; Scott Ryall; Pawel Buczkowicz; James Leach; Lili Miles; Arun Ramani; Michael Brudno; Shiva Senthil Kumar; Rachid Drissi; Phillip Dexheimer; Ralph Salloum; Lionel Chow; Trent Hummel; Charles Stevenson; Q Richard Lu; Blaise Jones; David Witte; Bruce Aronow; Cynthia E Hawkins; Maryam Fouladi
Journal:  Acta Neuropathol Commun       Date:  2016-01-04       Impact factor: 7.801

10.  Spatial and temporal homogeneity of driver mutations in diffuse intrinsic pontine glioma.

Authors:  Hamid Nikbakht; Eshini Panditharatna; Leonie G Mikael; Rui Li; Tenzin Gayden; Matthew Osmond; Cheng-Ying Ho; Madhuri Kambhampati; Eugene I Hwang; Damien Faury; Alan Siu; Simon Papillon-Cavanagh; Denise Bechet; Keith L Ligon; Benjamin Ellezam; Wendy J Ingram; Caedyn Stinson; Andrew S Moore; Katherine E Warren; Jason Karamchandani; Roger J Packer; Nada Jabado; Jacek Majewski; Javad Nazarian
Journal:  Nat Commun       Date:  2016-04-06       Impact factor: 14.919

View more
  8 in total

1.  RP-Rs-fMRIomics as a Novel Imaging Analysis Strategy to Empower Diagnosis of Brain Gliomas.

Authors:  Xiaoxue Liu; Jianrui Li; Qiang Xu; Qirui Zhang; Xian Zhou; Hao Pan; Nan Wu; Guangming Lu; Zhiqiang Zhang
Journal:  Cancers (Basel)       Date:  2022-06-07       Impact factor: 6.575

2.  Diagnostic Performance of 2D and 3D T2WI-Based Radiomics Features With Machine Learning Algorithms to Distinguish Solid Solitary Pulmonary Lesion.

Authors:  Qi Wan; Jiaxuan Zhou; Xiaoying Xia; Jianfeng Hu; Peng Wang; Yu Peng; Tianjing Zhang; Jianqing Sun; Yang Song; Guang Yang; Xinchun Li
Journal:  Front Oncol       Date:  2021-11-18       Impact factor: 6.244

Review 3.  Molecular Imaging of Brain Tumors and Drug Delivery Using CEST MRI: Promises and Challenges.

Authors:  Jianpan Huang; Zilin Chen; Se-Weon Park; Joseph H C Lai; Kannie W Y Chan
Journal:  Pharmaceutics       Date:  2022-02-20       Impact factor: 6.321

4.  Multiparametric MRI-Based Radiomics Model for Predicting H3 K27M Mutant Status in Diffuse Midline Glioma: A Comparative Study Across Different Sequences and Machine Learning Techniques.

Authors:  Wei Guo; Dejun She; Zhen Xing; Xiang Lin; Feng Wang; Yang Song; Dairong Cao
Journal:  Front Oncol       Date:  2022-03-03       Impact factor: 6.244

5.  Evaluation of Amide Proton Transfer-Weighted Imaging for Risk Factors in Stage I Endometrial Cancer: A Comparison With Diffusion-Weighted Imaging and Diffusion Kurtosis Imaging.

Authors:  Xingxing Jin; Ruifang Yan; Zhong Li; Gaiyun Zhang; Wenling Liu; Hongxia Wang; Meng Zhang; Jinxia Guo; Kaiyu Wang; Dongming Han
Journal:  Front Oncol       Date:  2022-04-14       Impact factor: 5.738

Review 6.  Review and consensus recommendations on clinical APT-weighted imaging approaches at 3T: Application to brain tumors.

Authors:  Jinyuan Zhou; Moritz Zaiss; Linda Knutsson; Phillip Zhe Sun; Sung Soo Ahn; Silvio Aime; Peter Bachert; Jaishri O Blakeley; Kejia Cai; Michael A Chappell; Min Chen; Daniel F Gochberg; Steffen Goerke; Hye-Young Heo; Shanshan Jiang; Tao Jin; Seong-Gi Kim; John Laterra; Daniel Paech; Mark D Pagel; Ji Eun Park; Ravinder Reddy; Akihiko Sakata; Sabine Sartoretti-Schefer; A Dean Sherry; Seth A Smith; Greg J Stanisz; Pia C Sundgren; Osamu Togao; Moriel Vandsburger; Zhibo Wen; Yin Wu; Yi Zhang; Wenzhen Zhu; Zhongliang Zu; Peter C M van Zijl
Journal:  Magn Reson Med       Date:  2022-04-22       Impact factor: 3.737

7.  Sensitivity and specificity of amide proton transfer-weighted imaging for assessing programmed death-ligand 1 status in non-small cell lung cancer: a comparative study with intravoxel incoherent motion and 18F-FDG PET.

Authors:  Nan Meng; Fangfang Fu; Jing Sun; Pengyang Feng; Yu Luo; Yaping Wu; Xiaochen Li; Jianmin Yuan; Yang Yang; Hui Liu; Zhe Wang; Meiyun Wang
Journal:  Quant Imaging Med Surg       Date:  2022-09

Review 8.  Artificial intelligence in the radiomic analysis of glioblastomas: A review, taxonomy, and perspective.

Authors:  Ming Zhu; Sijia Li; Yu Kuang; Virginia B Hill; Amy B Heimberger; Lijie Zhai; Shengjie Zhai
Journal:  Front Oncol       Date:  2022-08-02       Impact factor: 5.738

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.